Literature DB >> 24443403

Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.

Rebecca E Graff1, Eunyoung Cho, Sara Lindström, Peter Kraft, Walter C Willett, A Heather Eliassen.   

Abstract

BACKGROUND: Evidence from the Nurses' Health Study II (NHSII) suggests that red meat consumption is associated with increased breast cancer risk in premenopausal women. Iron may be responsible by contributing to oxidative stress or effects on immune function.
METHODS: We conducted a case-control study nested within the NHSII, examining prediagnostic plasma ferritin (n = 795 cases, 795 controls), 15 hemochromatosis gene (HFE) single-nucleotide polymorphisms (SNP; n = 765 cases, 1,368 controls), and breast cancer risk. Cases were diagnosed after providing blood samples between 1996 and 1999. ORs and 95% confidence intervals (CI) were calculated for ferritin levels by conditional logistic regression and for HFE SNPs by unconditional logistic regression.
RESULTS: We did not observe a significant association between ferritin levels and breast cancer (top vs. bottom quartile multivariate OR: 1.05; 95% CI, 0.77-1.45; PTrend = 0.77). Results did not change when restricted to women who were premenopausal at blood draw, and were similar when cases were examined by hormone receptor status, and menopausal status at diagnosis. No HFE SNPs were significantly associated with breast cancer in a log-additive manner. Among controls, ferritin levels were nominally associated with SNPs rs9366637 (PTrend = 0.04), rs6918586 (PTrend = 0.06), and rs13161 (PTrend = 0.07), but results did not remain significant after adjusting for multiple testing.
CONCLUSIONS: Ferritin levels and HFE SNPs were not associated with breast cancer risk in this population. IMPACT: Components of red meat other than iron are likely responsible for its positive association with breast cancer in premenopausal women. ©2014 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24443403      PMCID: PMC3951649          DOI: 10.1158/1055-9965.EPI-13-0907

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  64 in total

1.  Epidemiologic evidence of an association between body iron stores and risk of cancer.

Authors:  J V Selby; G D Friedman
Journal:  Int J Cancer       Date:  1988-05-15       Impact factor: 7.396

2.  Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis.

Authors:  J M Gutteridge; D A Rowley; E Griffiths; B Halliwell
Journal:  Clin Sci (Lond)       Date:  1985-04       Impact factor: 6.124

3.  Iron inhibits the nonspecific tumoricidal activity of macrophages. A possible contributory mechanism for neoplasia in hemochromatosis.

Authors:  R Green; I Esparza; R Schreiber
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  Iron-binding proteins and risk of cancer in Taiwan.

Authors:  R G Stevens; R P Beasley; B S Blumberg
Journal:  J Natl Cancer Inst       Date:  1986-04       Impact factor: 13.506

5.  Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue.

Authors:  R Rossiello; M V Carriero; G G Giordano
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

6.  Nephrotoxicity and its prevention by vitamin E in ferric nitrilotriacetate-promoted lipid peroxidation.

Authors:  S Okada; S Hamazaki; Y Ebina; J L Li; O Midorikawa
Journal:  Biochim Biophys Acta       Date:  1987-10-31

7.  Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer.

Authors:  D M Marcus; N Zinberg
Journal:  J Natl Cancer Inst       Date:  1975-10       Impact factor: 13.506

Review 8.  Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases.

Authors:  B N Ames
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

9.  Transferrin and transferrin receptors in carcinoma of the breast.

Authors:  W P Faulk; B L Hsi; P J Stevens
Journal:  Lancet       Date:  1980-08-23       Impact factor: 79.321

10.  Tissue ferritin concentration in carcinoma of the breast.

Authors:  R E Weinstein; B H Bond; B K Silberberg
Journal:  Cancer       Date:  1982-12-01       Impact factor: 6.860

View more
  5 in total

1.  Plasma ferritin levels, HFE polymorphisms, and risk of pancreatic cancer among Chinese Han population.

Authors:  Zhiming Zhao; Chenggang Li; Minggeng Hu; Jidong Li; Rong Liu
Journal:  Tumour Biol       Date:  2014-05-06

2.  Circulating lipids, mammographic density, and risk of breast cancer in the Nurses' Health Study and Nurses' Health Study II.

Authors:  Sarah A Lucht; A Heather Eliassen; Kimberly A Bertrand; Thomas P Ahern; Signe Borgquist; Bernard Rosner; Susan E Hankinson; Rulla M Tamimi
Journal:  Cancer Causes Control       Date:  2019-07-01       Impact factor: 2.506

Review 3.  Cancer Progress and Priorities: Breast Cancer.

Authors:  Serena C Houghton; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-05       Impact factor: 4.090

4.  Association Between Serum Iron Biomarkers and Breast Cancer.

Authors:  Ann Von Holle; Katie M O'Brien; Dale P Sandler; Robert Janicek; Clarice R Weinberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-12-08       Impact factor: 4.090

5.  Natural selection on HFE in Asian populations contributes to enhanced non-heme iron absorption.

Authors:  Kaixiong Ye; Chang Cao; Xu Lin; Kimberly O O'Brien; Zhenglong Gu
Journal:  BMC Genet       Date:  2015-06-10       Impact factor: 2.797

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.